The growth of the market
is attributed to the increasing adoption of telomere performance programs for
leading a healthy life; growing focus on increasing healthy life expectancy
(HALE); increasing government focus towards preventive healthcare; rising
geriatric population and the subsequent growth in the need for cellular health
screening; increasing research activities; growing adoption of the direct-to-consumer
approach for the availability of kits; and increasing burden of chronic
diseases.
The global cellular
health screening market is estimated to reach USD 3.42 billion by 2022 from USD 2.12 billion in
2017, at a CAGR of 10.0% during the forecast period.
+ Market Dynamics
+ Drivers
+ Increasing Adoption of
Telomere Performance Programs for Leading A Healthy Life
+ Growing Importance of Healthy Life Expectancy (HALE)
+ Rising Government Focus Towards Preventive Healthcare
+ Rising Geriatric Population and Resultant Growth in the Need for Cellular
Health Screening
+ Increasing Research Activities
+ Growing Adoption of Direct-To-Consumer Approach for the Availability of Kits
+ Increasing Burden of Chronic Diseases
Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227041930
“Single test panels to dominate the market in 2017”
The global cellular health screening market is
segmented into single test panels and multi-test panels. In 2017, the single
test panels segment is expected to account for the largest share of the global
cellular health screening market. These panels are used to get accurate
information about a single biomarker and understand how it affects the health
of an individual. The preference for multi-test panels is increasing in the
market as they provide results for multiple biomarkers in a single exam.“Based on sample collection site, the at-home
segment is projected to grow at the highest CAGR”
The
global cellular health screening market is segmented into at-home, in-office,
and other sample collection sites. The at-home segment is expected to register
the highest CAGR during the forecast period. The availability of diagnostic and
therapeutic products that can be used by patients at home without assistance
from healthcare professionals are expected to boost the demand for cellular
health screening in this segment.
View complete press release:-
https://www.marketsandmarkets.com/PressReleases/cellular-health-screening-test.asp
